XML 73 R63.htm IDEA: XBRL DOCUMENT
v3.25.2

Net Loss Per Share - Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive (Details) - shares | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares | 58,859,524 | 326,402,133 | 58,859,524 | 326,402,133
Options [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares | 33,057,765 | 33,534,491 | 33,057,765 | 33,534,491
RSAs [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares | 8,079,896 | 5,678,013 | 8,079,896 | 5,678,013
RSUs [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares | 8,046,477 | 7,678,486 | 8,046,477 | 7,678,486
Public Warrants [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares | 9,675,386 |  | 9,675,386 |
Series A-1 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 50,997,533 |  | 50,997,533
Series A-2 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 47,849,869 |  | 47,849,869
Series A-3 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 9,503,120 |  | 9,503,120
Series B-1 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 44,047,138 |  | 44,047,138
Series B-2 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 30,539,060 |  | 30,539,060
Series B-3 [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 7,054,530 |  | 7,054,530
Series C [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 45,971,349 |  | 45,971,349
Series D [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 43,548,544 |  | 43,548,544
Total convertible redeemable preferred shares [Member] |  |  |  |
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive [Line Items] |  |  |  |
Anti-dilutive shares |  | 279,511,143 |  | 279,511,143

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesA1ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesA2ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesA3ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesB1ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesB2ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesB3ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesCConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_SeriesDConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bull_ConvertibleRedeemablePreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |